Mucomyst and Nifedipine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mucomyst (acetylcysteine) and Nifedipine (nifedipine). Common drug interactions include arteriosclerosis among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Mucomyst and Nifedipine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Mucomyst?

Mucomyst has active ingredients of acetylcysteine. eHealthMe is studying from 1,835 Mucomyst users. Check the latest studies of Mucomyst.

What is Nifedipine?

Nifedipine has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 53,459 Nifedipine users. Check the latest studies of Nifedipine.

On Jul, 19, 2026

12 people who take Mucomyst and Nifedipine together, and have interactions are studied.

Mucomyst and Nifedipine drug interactions.

What are the common drug interactions of Mucomyst and Nifedipine, by gender? *:

female:

Arteriosclerosis (thickening and hardening of arteries)
Blood creatinine increased
Bradycardia (abnormally slow heart action)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Cardiac failure congestive
Chest pain
Dyspnoea (difficult or laboured respiration)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Gastrointestinal ulcer

male:

Abdominal pain upper
Bacteraemia (presence of bacteria in the blood)
Dyspnoea (difficult or laboured respiration)
Nausea (feeling of having an urge to vomit)
Sepsis (a severe blood infection that can lead to organ failure and death)
Unresponsive to stimuli
Iodine uptake increased
Protein bound iodine increased

What are the common drug interactions of Mucomyst and Nifedipine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Eosinophilia (eosinophil count in the peripheral blood exceeds)
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Arteriosclerosis (thickening and hardening of arteries)
Bradycardia (abnormally slow heart action)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Cardiac failure congestive
Chest pain
Dyspnoea (difficult or laboured respiration)
Hyperkalaemia (damage to or disease of the kidney)

60+:

Abdominal pain upper
Bacteraemia (presence of bacteria in the blood)
Protein bound iodine increased
Dyspnoea (difficult or laboured respiration)
Nausea (feeling of having an urge to vomit)
Sepsis (a severe blood infection that can lead to organ failure and death)
Unresponsive to stimuli
Iodine uptake increased
Blood creatinine increased
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the existing conditions these people have? *

Renal Impairment (severely reduced kidney function): 3 people, 25.00%
Renal Artery Stenosis (narrowing of renal artery): 3 people, 25.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 25.00%
Tracheobronchitis (an inflammation or infection, which affects the trachea and bronchi of respiratory tract): 2 people, 16.67%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%
Anaesthesia: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Mucomyst and Nifedipine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously